Analyte Data

Analyte DataAnalyte Data2Analyte Data3


Targeted & Unbiased Analyte data can be downloaded from the following studies using the Query Tool

beta-amyloid (1-40, 1-42)

  1. Amyloid Burden in patients with Dementia with Lewy Bodies-Lumipulse G-CSF (beta-amyloid) PI: Diana Ziegler

C-Reactive Protein


  1. Beta-glucocerebrosidase activity in whole blood of patients with Lewy body dementias, disease controls, and healthy controls.  PI: Clemens Scherzer

IgG Index

  1. Adaptive immune response and cognition in Parkinson’s Disease-ELISA-Plasma/CSF (IgG, Albumin).  PI: Kathleen Poston


  1. Bridging the Gap between Genetic and Biomarker Cohorts-Harvard Biomarker Study-NeuroX.  PI: Clemens Scherzer
  2. Genome Wide SNP Analysis in Parkinson's Disease-NeuroX.  PI: Andy Singleton


  1. Identification of Epigenetic Signatures in Blood as Biomarkers for Parkinson's Disease-Infinium-Whole blood(DNA Methylation).  PI: Paula Desplats


  1. Evaluation of Glucocerebrosidase Pathway Biomarkers in Parkinson Disease-Mass Spec-Plasma/CSF (Sphingolipidomics).  PI: Rachel Saunders-Pullman
  2. GBA Meta-Analysis Initiative: Charting a Path to Success for Clinical Trials in Patients with GBA-PD-Mass Spec-Plasma(Sphingolipid).  PI: Clemens Scherzer
  3. GBA Pathway Markers for Lewy Body Dementias-Mass Spec-Plasma(Sphingolipid).  PI: Clemens Scherzer


  1. Metabolomics and Risk of Parkinson's Disease-Mass Spec-Blood (Metabolomics).  PI: Alberto Ascherio
  2. Metabolic Biomarkers of the Presymptomatic Phase of PD-NMR-Serum (Metabolomics).  PI: Sabrina Boulet